These compounds may serve as promising starting points for the development of new molecular design strategies targeting AD-related pathways.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most prevalent form of dementia, affecting millions of individuals worldwide.
📊
Key Findings & Data:In the present study, four novel N’-(diphenylmethylene)-3-(amino)propanehydrazide derivatives were designed, synthesized, and subsequently evaluated for their cholinesterase inhibitory and antioxidant activities.
💡
Conclusion & Impact:These compounds may serve as promising starting points for the development of new molecular design strategies targeting AD-related pathways.
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most prevalent form of dementia, affecting millions of individuals worldwide. It is characterized by a gradual decline in cognitive functions, ultimately impairing patients’ ability to perform daily activities. Multiple pathogenic mechanisms have been implicated in AD, including disturbances in the cholinergic system, oxidative stress, metal ion dysregulation, and amyloid-β (Aβ) aggregation. In the present study, four novel N’-(diphenylmethylene)-3-(amino)propanehydrazide derivatives were designed, synthesized, and subsequently evaluated for their cholinesterase inhibitory and antioxidant activities. These compounds may serve as promising starting points for the development of new molecular design strategies targeting AD-related pathways.
Güngör, B., Kılıç, B., Doğruer, D. (2025). Synthesis of N’-(diphenylmethylene)-3-(amino)propanehydrazide Derivatives and Evaluation for Cholinesterase Inhibitor and Antioxidant Activities. EMU Journal of Pharmaceutical Sciences, Volume: 8 Issue: 3. https://doi.org/10.54994/emujpharmsci.1834518
Bardakkaya M, Kilic B, Sagkan RI, Aksakal F, Shakila S, et al. (2023). Synthesis and evaluation of multitarget new 2-aminothiazole derivatives as potential anti-Alzheimer's agents. Archiv der Pharmazie 356(8): 2300054.
Blois MS (1958). Antioxidant Determinations by the Use of a Stable Free Radical. Nature 181(4617): 1199-1200.
Breijyeh Z, Karaman R (2020). Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules 25(24).
Chen LL, Fan YG, Zhao LX, Zhang Q, Wang ZY (2023). The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators. Bioorg Chem 131: 106301. Chen ZR, Huang JB, Yang SL, Hong FF (2022). Role of Cholinergic Signaling in Alzheimer's Disease. Molecules 27(6).
Ellman GL, Courtney KD, Andres VJ, Feather-Stone RM (1961). A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochemical Pharmacology 7: 88-95.
Feng Y, Wang X (2012). Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Longev 472932.
Kilic B, Bardakkaya M, Ilıkcı Sagkan R, Aksakal F, Shakila S, et al. (2023). New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against Alzheimer's disease: Design, synthesis, and biological evaluation. Bioorganic Chemistry 131: 106322.
Kilic B, Dogruer DS (2024). Synthesis and investigation of the cholinesterase inhibitory and antioxidant capacities of some novel N'-(quinolin-4-ylmethylene)propanehydrazides against Alzheimer's disease. Drug Development Research 85(3): e22183.
Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, et al. (2022). Alzheimer's Disease: Treatment Strategies and Their Limitations. Int J Mol Sci 23(22).